A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , |
| 格式: | Artículo |
| 語言: | en_US |
| 出版: |
2022
|
| 主題: | |
| 在線閱讀: | https://doi.org/10.3390/life12030327 https://www.mdpi.com/2075-1729/12/3/327/htm |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
